相关实验视频
Updated: Aug 3, 2026

Isolated Lung Perfusion System in the Rabbit Model
Published on: July 15, 2021
慢性支气管炎的症状和冠状动脉疾病的风险
P Jousilahti1, E Vartiainen, J Tuomilehto
1Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland.
慢性支气管炎症状显著增加男性和女性冠状动脉疾病的风险,独立于其他心血管因素. 管理呼吸道感染可能会降低心脏病死亡率.
科学领域:
- 心脏病学 心脏病学
- 流行病学 流行病学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 越来越多的证据将各种感染与冠心病联系起来.
- 呼吸道感染是重点关注的一个关键领域.
- 这项研究调查了慢性呼吸道感染作为冠状动脉心脏病的预测因素.
研究的目的:
- 为了确定慢性呼吸道感染是否预测冠心病发病率和死亡率.
- 评估这种关联是否独立于主要心血管风险因素.
- 检查协会是否因职业不同而有所不同.
主要方法:
- 一项为期13年的随访队列研究,对19,444名随机选择的芬兰男性和女性进行了随访.
- 由慢性支气管炎症状 (每年持续长达3个月) 定义的慢性呼吸道感染.
- 根据年龄,研究年份,吸烟,血清胆固醇和静脉血压进行调整的分析.
主要成果:
- 长期的慢性支气管炎症状增加了冠心病风险 (男性:RR 1.52,女性:RR 1.38) 和冠心病死亡风险 (男性:RR 1.74,女性:RR 1.49).
- 在对主要心血管风险因素进行调整后,这种关联仍然显著.
- 在蓝领和白领工人中风险相似,但在农民中没有观察到.
结论:
- 慢性支气管炎症状是冠状动脉疾病风险的独立预测因素.
- 如果因果性,预防和管理慢性呼吸道感染可能有助于减少冠心病死亡率.
更多相关视频
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
04:03Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations